Form 4: Director Sells SOPH Shares Under 10b5-1 Plan

Director Kathy L. Hibbs reported a sale of 7,508 ordinary shares of SOPHiA GENETICS SA under a pre-arranged trading plan.

Summary

• Kathy L. Hibbs, a Director at SOPHiA GENETICS SA, sold 7,508 ordinary shares on May 12, 2026.
• The transaction was executed under a Rule 10b5-1(c) trading plan, indicating it was pre-arranged.
• The sale occurred at a weighted average price of $4.6666 per share, with individual transactions ranging from $4.54 to $4.85.
• Following the sale, Hibbs beneficially owns 89,768 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the sale was conducted under a pre-established trading plan, mitigating concerns of opportunistic selling based on non-public information.

Negatives

• Director Kathy L. Hibbs sold a portion of her holdings.
• The sale represents a reduction in direct beneficial ownership by a key insider.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it solely reports a past transaction.

Industry Context

StockSavvy.ai notes that insider sales, particularly those conducted under Rule 10b5-1 plans, are common for portfolio management and liquidity. However, significant sales by directors can sometimes be interpreted by the market as a lack of confidence, depending on the volume and context.

Stakeholder Impact

• Shareholders may view the sale by a director with mixed sentiment, though the 10b5-1 plan mitigates negative interpretations.
• The company's management team is not directly impacted by this individual transaction, beyond the standard reporting requirements.

Key Dates

Keywords

SOPH, SOPHiA GENETICS SA, Form 4, Insider Trading, Rule 10b5-1, Share Sale, Director Transaction, Beneficial Ownership